Jill Marie Broadfoot - Net Worth and Insider Trading
Jill Marie Broadfoot Net Worth
The estimated net worth of Jill Marie Broadfoot is at least $96,657 dollars as of 2024-12-26. Jill Marie Broadfoot is the CFO of aTyr Pharma Inc and owns about 27,960 shares of aTyr Pharma Inc (ATYR) stock worth over $96,602. Jill Marie Broadfoot is also the Sr Vice President, CFO, Sec of Fresh Tracks Therapeutics Inc and owns about 74 shares of Fresh Tracks Therapeutics Inc (FRTX) stock worth over $55. Details can be seen in Jill Marie Broadfoot's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jill Marie Broadfoot has not made any transactions after 2024-05-31 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jill Marie Broadfoot
Jill Marie Broadfoot Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jill Marie Broadfoot owns 4 companies in total, including aTyr Pharma Inc (ATYR) , Fresh Tracks Therapeutics Inc (FRTX) , and Talphera Inc (TLPH) among others .
Click here to see the complete history of Jill Marie Broadfoot’s form 4 insider trades.
Insider Ownership Summary of Jill Marie Broadfoot
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ATYR | aTyr Pharma Inc | 2024-05-31 | Chief Financial Officer |
| FRTX | Fresh Tracks Therapeutics Inc | 2013-01-11 | Vice President & CFO & Secretary |
| TLPH | Talphera Inc | 2021-11-20 | director |
 | | 2021-08-18 | director |
Jill Marie Broadfoot Latest Holdings Summary
Jill Marie Broadfoot currently owns a total of 2 stocks. Among these stocks, Jill Marie Broadfoot owns 27,960 shares of aTyr Pharma Inc (ATYR) as of May 31, 2024, with a value of $96,602 and a weighting of 99.94%. Jill Marie Broadfoot also owns 74 shares of Fresh Tracks Therapeutics Inc (FRTX) as of January 11, 2013, with a value of $55 and a weighting of 0.06%.
Latest Holdings of Jill Marie Broadfoot
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ATYR | aTyr Pharma Inc | 2024-05-31 | 27,960 | 3.46 | 96,602 |
| FRTX | Fresh Tracks Therapeutics Inc | 2013-01-11 | 74 | 0.74 | 55 |
Holding Weightings of Jill Marie Broadfoot
Jill Marie Broadfoot Form 4 Trading Tracker
According to the SEC Form 4 filings, Jill Marie Broadfoot has made a total of 7 transactions in aTyr Pharma Inc (ATYR) over the past 5 years, including 3 buys and 4 sells. The most-recent trade in aTyr Pharma Inc is the acquisition of 5,000 shares on May 31, 2024, which cost Jill Marie Broadfoot around $8,950.
According to the SEC Form 4 filings, Jill Marie Broadfoot has made a total of 0 transactions in Fresh Tracks Therapeutics Inc (FRTX) over the past 5 years. The most-recent trade in Fresh Tracks Therapeutics Inc is the acquisition of 9 shares on January 11, 2013, which cost Jill Marie Broadfoot around $271.
Insider Trading History of Jill Marie Broadfoot
- 1
Jill Marie Broadfoot Trading Performance
GuruFocus tracks the stock performance after each of Jill Marie Broadfoot's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jill Marie Broadfoot is -11.8%. GuruFocus also compares Jill Marie Broadfoot's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jill Marie Broadfoot within 3 months outperforms 2 times out of 8 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jill Marie Broadfoot's insider trading performs compared to the benchmark.
Performance of Jill Marie Broadfoot
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -5.68 | | | | | |
| Relative Return to S&P 500(%) | -5.29 | | | | | |
Jill Marie Broadfoot Ownership Network
Jill Marie Broadfoot Owned Company Details
What does aTyr Pharma Inc do?
Who are the key executives at aTyr Pharma Inc?
Jill Marie Broadfoot is the Chief Financial Officer of aTyr Pharma Inc. Other key executives at aTyr Pharma Inc include Chief Medical Officer Sanjay Shukla , See Remarks Nancy Krueger , and director & CEO and Executive Chairman John Mendlein .
aTyr Pharma Inc (ATYR) Insider Trades Summary
Over the past 18 months, Jill Marie Broadfoot made 2 insider transaction in aTyr Pharma Inc (ATYR) with a net purchase of 3,410. Other recent insider transactions involving aTyr Pharma Inc (ATYR) include a net purchase of 65,000 shares made by Sanjay Shukla , a net purchase of 100,000 shares made by Paul Schimmel , and a net purchase of 50,000 shares made by Timothy P Coughlin .
In summary, during the past 3 months, insiders sold 0 shares of aTyr Pharma Inc (ATYR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,590 shares of aTyr Pharma Inc (ATYR) were sold and 225,000 shares were bought by its insiders, resulting in a net purchase of 223,410 shares.
aTyr Pharma Inc (ATYR)'s detailed insider trading history can be found in Insider Trading Tracker table.
aTyr Pharma Inc Insider Transactions
Jill Marie Broadfoot Mailing Address
Above is the net worth, insider trading, and ownership report for Jill Marie Broadfoot. You might contact Jill Marie Broadfoot via mailing address: 3545 John Hopkins Court, Suite 250, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
